Antares Pharma Inc. (ATRS)

2.53
0.01 0.40
NASDAQ : Health Technology
Prev Close 2.52
Open 2.52
Day Low/High 2.50 / 2.58
52 Wk Low/High 1.58 / 4.09
Volume 549.53K
Avg Volume 1.22M
Exchange NASDAQ
Shares Outstanding 156.83M
Market Cap 390.50M
EPS -0.10
P/E Ratio N/A
Div & Yield N.A. (N.A)
Quant Rating on 4:00 PM EDT 5/21/2018
Insider Trading Alert - ATRS, SJW And N Traded By Insiders

Insider Trading Alert - ATRS, SJW And N Traded By Insiders

Stocks with insider trader activity include ATRS, SJW and N

Antares Pharma Reports Second Quarter 2015 Operating And Financial Results

Antares Pharma Reports Second Quarter 2015 Operating And Financial Results

Antares Pharma, Inc. (NASDAQ:ATRS) today reported operating and financial results for the second quarter ended June 30, 2015.

Antares Pharma Announces First Patients Enrolled In QuickShot® Testosterone Supplemental Safety Study

Antares Pharma Announces First Patients Enrolled In QuickShot® Testosterone Supplemental Safety Study

Antares Pharma, Inc. (NASDAQ: ATRS) today announced that the first patients have been enrolled in a double-blind, multiple-dose, 26-week safety and pharmacokinetic study of QuickShot ® Testosterone (QS T) administered...

Antares Pharma To Host Second Quarter 2015 Operating And Financial Results Conference Call

Antares Pharma To Host Second Quarter 2015 Operating And Financial Results Conference Call

Antares Pharma, Inc. (NASDAQ: ATRS) today announced it will release its second quarter 2015 financial results before the market opens on Monday, August 10, 2015, and host a webcast and conference call shortly thereafter at...

Antares Pharma Appoints Peter J. Graham, Esq., Senior Vice President, General Counsel, Human Resources, Chief Compliance Officer And Corporate Secretary

Antares Pharma Appoints Peter J. Graham, Esq., Senior Vice President, General Counsel, Human Resources, Chief Compliance Officer And Corporate Secretary

Antares Pharma, Inc. (NASDAQ:ATRS) today announced the appointment of Peter J.

Drawing Up a Potential Shopping List

With Greece-related weakness and our large cash position, we'll consider putting money to work.

Short Interest Makes 11% Move For ATRS

Short Interest Makes 11% Move For ATRS

The most recent short interest data has been released by the NASDAQ for the 06/15/2015 settlement date, which shows a 879,418 share increase in total short interest for Antares Pharma Inc. , to 8,950,634, an increase of 10.90% since 05/29/2015.

First Week of February 2016 Options Trading For Antares Pharma (ATRS)

First Week of February 2016 Options Trading For Antares Pharma (ATRS)

Investors in Antares Pharma Inc. saw new options become available this week, for the February 2016 expiration.

Antares Pharma To Present At The JMP Securities Life Sciences Conference

Antares Pharma To Present At The JMP Securities Life Sciences Conference

Antares Pharma, Inc. (NASDAQ: ATRS) today announced that Eamonn P.

Sell These 7 Health Care Supplies Companies Now

Sell These 7 Health Care Supplies Companies Now

An aging population means the outlook is positive for health care equipment and supplies companies, but not every stock in the industry is a buy.

Antares Pharma Announces Additional Update To QuickShot Testosterone Program

Antares Pharma Announces Additional Update To QuickShot Testosterone Program

Antares Pharma, Inc. (NASDAQ: ATRS) today announced that it has received a written update from the U.

Antares Pharma To Present At The Jefferies 2015 Global Healthcare Conference

Antares Pharma To Present At The Jefferies 2015 Global Healthcare Conference

Antares Pharma, Inc. (NASDAQ: ATRS) today announced that James E.

Antares Pharma Announces Closing Of Public Offering Of Common Stock

Antares Pharma Announces Closing Of Public Offering Of Common Stock

Antares Pharma, Inc. (NASDAQ: ATRS) today announced the closing of its previously announced firm commitment underwritten public offering of 23,000,000 shares of the Company's common stock, which includes 3,000,000 shares...

First Week of June 19th Options Trading For Antares Pharma (ATRS)

First Week of June 19th Options Trading For Antares Pharma (ATRS)

Investors in Antares Pharma Inc. saw new options begin trading this week, for the June 19th expiration.

First Week of November 20th Options Trading For Antares Pharma (ATRS)

First Week of November 20th Options Trading For Antares Pharma (ATRS)

Investors in Antares Pharma Inc. saw new options become available this week, for the November 20th expiration.

Insider Trading Alert - GMAN, ATRS And MMI Traded By Insiders

Insider Trading Alert - GMAN, ATRS And MMI Traded By Insiders

Stocks with insider trader activity include GMAN, ATRS and MMI

Antares Pharma Reports Fourth Quarter And Full Year 2014 Operating And Financial Results

Antares Pharma Reports Fourth Quarter And Full Year 2014 Operating And Financial Results

Antares Pharma, Inc. (NASDAQ: ATRS) today reported operating and financial results for the fourth quarter and full year ended December 31, 2014.

Antares Pharma To Host Fourth Quarter 2014 Operating And Financial Results Conference Call

Antares Pharma To Host Fourth Quarter 2014 Operating And Financial Results Conference Call

Antares Pharma, Inc. (NASDAQ: ATRS) today announced it will release its fourth quarter 2014 financial results before the market opens on Thursday, March 12, 2015, and host a conference call shortly thereafter at 8:30 a.

TheStreet Quant Rating: D (Sell)